Summary
The National Committee for Quality Assurance (NCQA) has released its Healthcare Effectiveness Data and Information Set (HEDIS®) 2025 changes for hypertension measurement.
The changes include the following:1
- A new measure, Blood Pressure Control for Patients with Hypertension (BPC-E), replaced the hybrid measure Controlling High Blood Pressure (CBP). The prior measure used a hybrid reporting method of electronic data and chart reviews. The updated version will only use an Electronic Clinical Data Systems (ECDS) reporting method using claims data coding and pharmacy data, which expands the tool’s scope.2
- BPC-E will report on the percentage of members ages 18 to 85 with hypertension whose most recent blood pressure was lower than 140/90 mmHg during the measurement period. This is a logic change that requires reporting of the most recent BP if more than one blood pressure measure is available on the latest date of service. The new BPC-E measure requires the use of the latest systolic and diastolic blood pressure reading that day, whereas the CBP measure took the lowest systolic and diastolic BP readings of the day.
- BPC-E expands diagnosis criteria, adding members with one outpatient or telehealth hypertension diagnosis and a dispensed antihypertensive medication in the prior year or the first six months of the measurement period.
- This measure is stratified by race and ethnicity.
Sources
1. National Committee for Quality Assurance. HEDIS MY 2025: What’s New, What’s Changed, What’s Retired. https://www.ncqa.org/blog/hedis-my-2025-whats-new-whats-changed-whats-retired. August 1, 2024. Accessed 10/4/2024.
2. National Committee for Quality Assurance. HEDIS Electronic Clinical Data Systems (ECDS) Reporting. https://www.ncqa.org/hedis/the-future-of-hedis/hedis-electronic-clinical-data-system-ecds-reporting. Accessed October 8, 2024.